Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1,001 - 1,050 out of 12,280

Document Document Title
WO/2007/123269A1
[PROBLEMS] To provide a therapeutic or prophylactic agent for frequent urination/strong urge to urinate or incontinence associated with overactive bladder, a lower urinary tract disease accompanied by a lower urinary tract pain such as i...  
WO/2007/119106A3
The invention relates, in general, to an improved process for the preparation of the compounds (3R,4S)-4-(4-(benzyloxy)phenyl)-l-(4-fluorophenyl)-3-[3-(4-f luorophenyl)-3- oxopropyl]azetidin-2-one and (3R,4S)-l-(4-fluorophenyl)-3-[3-(4-f...  
WO/2007/120638A2
The invention relates to methods and products for modulating glycosylation of proteins. The invention is useful for treating glycosylation-associated disorders such as neurodegeneration, diabetes, including complications of diabetes such...  
WO/2007/119106A2
The invention relates, in general, to an improved process for the preparation of the compounds (3R,4S)-4-(4-(benzyloxy)phenyl)-l-(4-fluorophenyl)-3-[3-(4-f luorophenyl)-3- oxopropyl]azetidin-2-one and (3R,4S)-l-(4-fluorophenyl)-3-[3-(4-f...  
WO/2007/120638A3
The invention relates to methods and products for modulating glycosylation of proteins. The invention is useful for treating glycosylation-associated disorders such as neurodegeneration, diabetes, including complications of diabetes such...  
WO/2007/119887A1
A compound represented by the general formula (II) below or a salt thereof is used as an activating agent for PPAR δ. (II) (In the formula, Ga represents O, CH2 or the like; Aa represents a thiazole, oxazole or thiophene which may have ...  
WO/2007/117591A2
The present invention relates to certain compounds and to methods for the preparation of certain compounds that can be used in the fields of chemistry and medicine. Specifically, described herein are methods for the preparation of variou...  
WO/2007/117591A3
The present invention relates to certain compounds and to methods for the preparation of certain compounds that can be used in the fields of chemistry and medicine. Specifically, described herein are methods for the preparation of variou...  
WO/2007/116960A1
Disclosed is a novel oxazolidinone derivative represented by the formula (I). Also disclosed is an antibacterial agent comprising the derivative, wherein the ring A represents an at least 7-membered monocyclic carbocyclic ring which may ...  
WO/2007/116374A1
The invention relates to sulfonamide compounds of formula (I), where A, B, R3 and R4 are as defined in the claims, and their use as orexin receptor antagonists in the prevention and treatment of eating and drinking disorders, all types o...  
WO/2007/116284A1
The present invention relates to a new process for preparing the oxazolidinone antibacterial agent linezolid which comprises the reaction of an (S)-I -chloro-3- (benzyIidenylamino)-propan-2-ol with a morpholinyl fluorophenyl carbamate to...  
WO/2007/113327A2
The present invention relates to N-cyclopropyl-sulfonylamide derivatives of formula (I) wherein the substituents are cyclic groups, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide...  
WO/2007/113327A3
The present invention relates to N-cyclopropyl-sulfonylamide derivatives of formula (I) wherein the substituents are cyclic groups, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide...  
WO/2007/110727A2
This invention pertains to amide and ester derivatives of hydroxyethylamine compounds that serve as effective beta-secretase inhibitors. The invention further relates to intermediates for preparation of such compounds; pharmaceutical com...  
WO/2007/111179A1
The object is to provide: a diagnostic imaging agent for early and accurate diagnosis of a disease associated with the accumulation of amyloid-β protein; and a composition comprising the diagnostic imaging agent. Disclosed is an aminost...  
WO/2007/111136A1
Disclosed is a curable epoxy resin composition characterized by containing a compound having a benzoxazole structure represented by the general formula (I) below. (I) (In the formula, X1 and X2 independently represent a hydrogen atom, a ...  
WO/2007/110727A3
This invention pertains to amide and ester derivatives of hydroxyethylamine compounds that serve as effective beta-secretase inhibitors. The invention further relates to intermediates for preparation of such compounds; pharmaceutical com...  
WO/2007/110364A1
Certain novel benzothiazoles and benzoxazoles, e.g., 2-(piperazin-1-yl)benzothiazoles and 2-(piperazin-1-yl)benzoxazoles, optionally substituted in the 3 and/or 4 positions of the piperazine rings,! of the general formula (l): having his...  
WO/2007/111323A1
Discloses is a pharmaceutical agent comprising an ureide derivative represented by the formula: or a pharmaceutically acceptable salt thereof as an active ingredient. The ureide derivative or the pharmaceutically acceptable salt thereof ...  
WO/2007/111864A3
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.  
WO/2007/107311A3
The invention relates to special sulphinic acid derivatives of formula (I), wherein M represents a hydrogen atom or an equivalent of a monovalent or polyvalent cation, R is derived from a peptide or represents a group according to one of...  
WO/2007/107311A2
The invention relates to special sulphinic acid derivatives of formula (I), wherein M represents a hydrogen atom or an equivalent of a monovalent or polyvalent cation, R is derived from a peptide or represents a group according to one of...  
WO/2007/104557A3
The present invention relates to compounds of the general formula (Ih) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof, (Ih) wherein A is NR2, S or O;...  
WO/2007/104557A2
The present invention relates to compounds of the general formula (Ih) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof, (Ih) wherein A is NR2, S or O;...  
WO/2007/106818A1
The subject invention pertains to pentafluorosulfanyl (-SF5) substituted compounds and methods of their synthesis. The subject invention provides convenient methods to incorporate the -SF5 substituent into compounds such as heterocycles ...  
WO/2007/104144A1
There are provided compounds represented by formula (I): in which R1 is F, CI, -N(R5)2 or -CN and Q+ is selected among various organic cations that include an heterocyle. These compounds are useful as electrolytes, ionic liquids or molte...  
WO/2007/103456A3
This invention relates to piperazine and piperidine biaryl compounds of Formula (I) or a pharmaceutically acceptable prodrug, salt, polymorph, solvate, enantiomer, diastereomer, racemate, mixture of stereoisomers thereof, or derivative t...  
WO/2007/099828A1
Nitrogenous heterocyclic derivatives represented by the general formula (I) which each bind specifically to NR1/NR2B receptor and are useful as NR2B receptor antagonists (particularly analgesic for cancer pain or neuroprotectant); pharma...  
WO/2007/097992A3
The present invention relates to novel heterocyclic diphenyl ether and diphenyl amine compounds, derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and pharmaceuticall...  
WO/2007/095050A2
The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions containing the same and methods for the treatment of IDO-associated diseases.  
WO2007073518A9
Methods for therapy of cystic fibrosis and other conditions such as cancer are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system (i.e., ABC transporters s...  
WO/2007/093292A3
Certain substituted amino heterocyclic and heteroaryl derivatives have provided unexpected insecticidal and acaricidal activity. These compounds are represented by formula (I): wherein R, R1, R2, R3, R4, A, B and Q are fully described he...  
WO/2007/093507A1
The invention is concerned with novel heterobicyclic derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6, V, W, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters the...  
WO/2007/095050A3
The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions containing the same and methods for the treatment of IDO-associated diseases.  
WO/2007/094480A1
A method of stereoselectively producing an optically active alcohol characterized by comprising reducing an aromatic ketone by using an optically active 2-[bis(4-methoxyphenyl)hydroxymethyl]pyrrolidine, sodium borohydride and chlorotrime...  
WO/2007/091009A3
It comprises a process for the production of delmopinol or a pharmaceutically acceptable salt and/or a solvate thereof, by subjecting the compound of formula (II) where R1 and R2 are the same or different, independently selected from the...  
WO/2007/091009A2
It comprises a process for the production of delmopinol or a pharmaceutically acceptable salt and/or a solvate thereof, by subjecting the compound of formula (II) where R1 and R2 are the same or different, independently selected from the...  
WO/2007/092961A3
This invention provides compositions which are l,3-oxazinan-2-one compounds of formulae (I) and (II), and oxazolidinone compounds of formula (III): wherein R is a hydrocarbyl group, a heterocyclic group, a hydrocarbyl group having at lea...  
WO/2007/092961A2
This invention provides compositions which are l,3-oxazinan-2-one compounds of formulae (I) and (II), and oxazolidinone compounds of formula (III): wherein R is a hydrocarbyl group, a heterocyclic group, a hydrocarbyl group having at lea...  
WO/2007/091313A1
A heterocyclic phenoxy derivative represented by the formula (1a): (1a) wherein Y represents an oxygen or sulfur atom; (R1)m represents a hydrogen or halogen atom, an alkyl group or the like; (R2)n represents a hydrogen or halogen atom, ...  
WO/2007/092190A2
The present invention relates to compounds which modulate the activity of the SlPl receptor, the use of these compounds for treating conditions associated with signaling through the SlPl receptor, and pharmaceutical compositions comprisi...  
WO/2007/092190A3
The present invention relates to compounds which modulate the activity of the SlPl receptor, the use of these compounds for treating conditions associated with signaling through the SlPl receptor, and pharmaceutical compositions comprisi...  
WO/2007/087906A1
The present invention relates to N-cycloalkyl-benzyl-amide derivatives of formula (I) wherein the substituents are as in the description, their process of preparation, their use as fungicide active agents, particularly in the form of fun...  
WO/2007/089548A3
Disclosed are compositions and methods for modulating protein trafficking and treating or preventing disorders characterized by impaired protein trafficking. Also disclosed are methods for identification of compounds that rescue protein ...  
WO2007014290B1
This invention is directed to compounds of Formula (1) including all geometric and stereoisomers, N oxides, and agriculturally suitable salts thereof, agricultural compositions containing them and their use as fungicides, (1) provided th...  
WO/2007/089044A1
Disclosed is a process for production of an aromatic compound represented by the formula (3), wherein the process comprises reacting a compound represented by the formula (1) with an olefin compound represented by the formula (2) in the ...  
WO/2007/086584A1
Disclosed is a compound which can inhibit both of FabI and FabK which are fatty acid synthases to show a wide antibacterial spectrum including Streptococcus pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, and therefore can ...  
WO/2007/085203A1
The substituted pentabasic azaheterocyclic compounds of formula I and/or its pharmacological salts and hydrates are provided in the present invention, the groups in the formula are defined as the description. The medicinal composition co...  
WO/2007/085202A1
Compounds represented by the general formula I, their pharmaceutically acceptable salts, solvates are disclosed. The definitions of substituents of formula I are the same as description. The pharmaceutical compositions containing the com...  
WO/2007/083320A2
The present invention relates to the preparation of aryl hydrazines and their salts by treating aryl diazonium salts with triphenyl phosphine followed by hydrolysis of the resulting triphenyl-aryl hydrazyl phosphonium salt to get aryl hy...  

Matches 1,001 - 1,050 out of 12,280